20/20 Biolabs Inc. (AIDX) vs CalciMedica, Inc. (CALC)

A side-by-side comparison of 20/20 Biolabs Inc. and CalciMedica, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
20/20 Biolabs Inc. logo
AIDX
20/20 Biolabs Inc.
$4M
$0.34HealthcareDelayed quote: Oct 6, 2026, 11:24 AM EDT
CalciMedica, Inc. logo
CALC
CalciMedica, Inc.
$5M
$1.58HealthcareDelayed quote: Oct 6, 2026, 11:20 AM EDT

Total return — AIDX vs CALC

growth of $100 · dividends reinvested · last 1y
AIDX -98.5% (-98.5%/yr)CALC -41.0% (-41.0%/yr)CALC compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100$1$59
AIDX CALC

AIDX vs CALC: by the numbers

  • •CALC is the larger company ($5M vs $4M market cap).
  • •Both run net losses; CALC's is the smaller (0.00% vs -285.00% net margin).

Metrics side by side

Valuation

MetricAIDXCALC
P/S ratio2.07N/A
P/B ratio2.600.90

Profitability

MetricAIDXCALC
Gross margin31.52%0.00%
Operating margin-162.87%0.00%
Net margin-285.00%0.00%
ROE-184.04%-385.27%
ROIC-116.89%-122.56%

Growth (annualized)

MetricAIDXCALC
Revenue CAGR (5Y)-2.58%N/A

Go deeper

Full AIDX analysisFull CALC analysisInteractive comparison tool

Dig into the metrics

20/20 Biolabs ROECalciMedica ROE20/20 Biolabs operating marginCalciMedica operating margin20/20 Biolabs revenue growthCalciMedica revenue growth20/20 Biolabs free cash flowCalciMedica free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.